Skip to main content
Top
Published in: Indian Journal of Pediatrics 3/2024

Open Access 13-07-2023 | Hepatorenal Syndrome | Review Article

Systemic Complications Secondary to Chronic Liver Disease

Authors: Rory Mannion, Emer Fitzpatrick

Published in: Indian Journal of Pediatrics | Issue 3/2024

Login to get access

Abstract

The systemic sequelae of chronic liver disease (CLD) may be due to portal hypertension and shunting, malnutrition, and/or a low grade inflammatory state. This article will focus on the consequences of chronic liver disease affecting extrahepatic organs. Portal hypertension underlies many systemic complications of CLD. Aside from varices and ascites, portal hypertension may cause both hepatopulmonary syndrome and portopulmonary hypertension leading to respiratory compromise. Cardiomyopathy may also occur secondary to end stage liver disease. Hepatorenal syndrome is also well recognised and hepatic encephalopathy is a consequence of the effect of liver dysfunction on the brain. Compromise of the immune system is well described in end-stage liver disease leading to sepsis and its consequences. Bony disease including osteoporosis and hepatic arthropathy may both be seen in children with CLD. CLD may be asymptomatic initially but then complications may present as the disease progresses. Furthermore, systemic effects of end stage liver disease may complicate liver transplant. These complications often present insidiously or at the time of acute decompensation. Thus, it is important that healthcare providers are vigilant when caring for children with CLD. This article outlines the secondary complications of CLD with an overview of the definition and diagnosis, pathophysiology, management and prognosis of each.
Literature
1.
go back to reference García-Pagán JC, Gracia-Sancho J, Bosch J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol. 2012;57:458–61.CrossRefPubMed García-Pagán JC, Gracia-Sancho J, Bosch J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol. 2012;57:458–61.CrossRefPubMed
2.
go back to reference Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353–90.CrossRefPubMed Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353–90.CrossRefPubMed
3.
go back to reference Mouzaki M, Bronsky J, Gupte G, et al. Nutrition support of children with chronic liver diseases: a joint position paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the european Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2019;69:498–511.CrossRefPubMed Mouzaki M, Bronsky J, Gupte G, et al. Nutrition support of children with chronic liver diseases: a joint position paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the european Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2019;69:498–511.CrossRefPubMed
4.
go back to reference Carpenter A, Ng VL, Chapman K, Ling SC, Mouzaki M. Predictive equations are inaccurate in the estimation of the resting energy expenditure of children with end-stage liver disease. JPEN J Parenter Enteral Nutr. 2017;41:507–11.CrossRefPubMed Carpenter A, Ng VL, Chapman K, Ling SC, Mouzaki M. Predictive equations are inaccurate in the estimation of the resting energy expenditure of children with end-stage liver disease. JPEN J Parenter Enteral Nutr. 2017;41:507–11.CrossRefPubMed
5.
go back to reference Bolia R, Srivastava A, Marak R, Yachha SK, Poddar U. Prevalence and impact of bacterial infections in children with liver disease-A prospective study. J Clin Exp Hepatol. 2018;8:35–41.CrossRefPubMed Bolia R, Srivastava A, Marak R, Yachha SK, Poddar U. Prevalence and impact of bacterial infections in children with liver disease-A prospective study. J Clin Exp Hepatol. 2018;8:35–41.CrossRefPubMed
6.
go back to reference Campbell KA, Trivedi HD, Chopra S. Infections in cirrhosis: a guide for the clinician. Am J Med. 2021;134:727–34.CrossRefPubMed Campbell KA, Trivedi HD, Chopra S. Infections in cirrhosis: a guide for the clinician. Am J Med. 2021;134:727–34.CrossRefPubMed
7.
go back to reference Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the study of Liver Diseases. Hepatology. 2021;74:1014–48.CrossRefPubMed Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the study of Liver Diseases. Hepatology. 2021;74:1014–48.CrossRefPubMed
8.
go back to reference Srivastava A, Malik R, Bolia R, Yachha SK, Poddar U. Prevalence, clinical profile, and outcome of ascitic fluid infection in children with liver disease. J Pediatr Gastroenterol Nutr. 2017;64:194–9.CrossRefPubMed Srivastava A, Malik R, Bolia R, Yachha SK, Poddar U. Prevalence, clinical profile, and outcome of ascitic fluid infection in children with liver disease. J Pediatr Gastroenterol Nutr. 2017;64:194–9.CrossRefPubMed
10.
go back to reference Srivastava A, Chaturvedi S, Gupta RK, et al. Minimal hepatic encephalopathy in children with chronic liver disease: prevalence, pathogenesis and magnetic resonance-based diagnosis. J Hepatol. 2017;66:528–36.CrossRefPubMed Srivastava A, Chaturvedi S, Gupta RK, et al. Minimal hepatic encephalopathy in children with chronic liver disease: prevalence, pathogenesis and magnetic resonance-based diagnosis. J Hepatol. 2017;66:528–36.CrossRefPubMed
11.
go back to reference Krowka MJ, Fallon MB, Kawut SM, et al. International Liver Transplant Society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation. 2016;100:1440–52.CrossRefPubMed Krowka MJ, Fallon MB, Kawut SM, et al. International Liver Transplant Society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation. 2016;100:1440–52.CrossRefPubMed
12.
go back to reference Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2014;20:8072–81.CrossRefPubMedPubMedCentral Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2014;20:8072–81.CrossRefPubMedPubMedCentral
13.
go back to reference Noli K, Solomon M, Golding F, Charron M, Ling SC. Prevalence of hepatopulmonary syndrome in children. Pediatrics. 2008;121:e522–7.CrossRefPubMed Noli K, Solomon M, Golding F, Charron M, Ling SC. Prevalence of hepatopulmonary syndrome in children. Pediatrics. 2008;121:e522–7.CrossRefPubMed
14.
go back to reference Sari S, Oguz D, Sucak T, Dalgic B, Atasever T. Hepatopulmonary syndrome in children with cirrhotic and non-cirrhotic portal hypertension: a single-center experience. Dig Dis Sci. 2012;57:175–81.CrossRefPubMed Sari S, Oguz D, Sucak T, Dalgic B, Atasever T. Hepatopulmonary syndrome in children with cirrhotic and non-cirrhotic portal hypertension: a single-center experience. Dig Dis Sci. 2012;57:175–81.CrossRefPubMed
16.
go back to reference Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology. 2014;59:1627–37.CrossRefPubMed Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology. 2014;59:1627–37.CrossRefPubMed
17.
go back to reference Willis AD, Miloh TA, Arnon R, Iyer KR, Suchy FJ, Kerkar N. Hepatopulmonary syndrome in children - is conventional liver transplantation always needed? Clin Transpl. 2011;25:849–55.CrossRef Willis AD, Miloh TA, Arnon R, Iyer KR, Suchy FJ, Kerkar N. Hepatopulmonary syndrome in children - is conventional liver transplantation always needed? Clin Transpl. 2011;25:849–55.CrossRef
18.
go back to reference Warner S, McKiernan PJ, Hartley J, et al. Hepatopulmonary syndrome in children: a 20-year review of presenting symptoms, clinical progression, and transplant outcome. Liver Transpl. 2018;24:1271–9.CrossRefPubMed Warner S, McKiernan PJ, Hartley J, et al. Hepatopulmonary syndrome in children: a 20-year review of presenting symptoms, clinical progression, and transplant outcome. Liver Transpl. 2018;24:1271–9.CrossRefPubMed
19.
go back to reference Raghunathan V, Mohan N, Dhaliwal M, Bhangui P, Vohra V, Soin AS. Pediatric liver transplantation in severe hepatopulmonary syndrome and use of inhaled nitric oxide for post-transplant hypoxemia-a single center experience. Pediatr Transpl. 2020;24:e13792.CrossRef Raghunathan V, Mohan N, Dhaliwal M, Bhangui P, Vohra V, Soin AS. Pediatric liver transplantation in severe hepatopulmonary syndrome and use of inhaled nitric oxide for post-transplant hypoxemia-a single center experience. Pediatr Transpl. 2020;24:e13792.CrossRef
20.
go back to reference Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003;125:1042–52.CrossRefPubMed Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003;125:1042–52.CrossRefPubMed
21.
go back to reference Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology. 1991;100:520–8.CrossRefPubMed Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology. 1991;100:520–8.CrossRefPubMed
22.
go back to reference Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20:271–9.CrossRefPubMed Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20:271–9.CrossRefPubMed
23.
go back to reference Liu PMF, de Carvalho ST, Fradico PF, Cazumbá MLB, Campos RGB. Simões E Silva AC. Hepatorenal syndrome in children: a review. Pediatr Nephrol. 2021;36:2203–15.CrossRefPubMed Liu PMF, de Carvalho ST, Fradico PF, Cazumbá MLB, Campos RGB. Simões E Silva AC. Hepatorenal syndrome in children: a review. Pediatr Nephrol. 2021;36:2203–15.CrossRefPubMed
25.
go back to reference Wang L, Long Y, Li KX, Xu GS. Pharmacological treatment of hepatorenal syndrome: a network meta-analysis. Gastroenterol Rep (Oxf). 2020;8:111–8.CrossRefPubMed Wang L, Long Y, Li KX, Xu GS. Pharmacological treatment of hepatorenal syndrome: a network meta-analysis. Gastroenterol Rep (Oxf). 2020;8:111–8.CrossRefPubMed
27.
go back to reference Deep A, Saxena R, Jose B. Acute kidney injury in children with chronic liver disease. Pediatr Nephrol. 2019;34:45–59.CrossRefPubMed Deep A, Saxena R, Jose B. Acute kidney injury in children with chronic liver disease. Pediatr Nephrol. 2019;34:45–59.CrossRefPubMed
28.
go back to reference Lacquaniti A, Campo S, Di Casuscelli T, et al. Acute and chronic kidney disease after pediatric liver transplantation: an underestimated problem. Clin Transpl. 2020;34:e14082.CrossRef Lacquaniti A, Campo S, Di Casuscelli T, et al. Acute and chronic kidney disease after pediatric liver transplantation: an underestimated problem. Clin Transpl. 2020;34:e14082.CrossRef
29.
go back to reference Junge N, Junge C, Schröder J, et al. Pediatric cirrhotic cardiomyopathy: impact on liver transplant outcomes. Liver Transpl. 2018;24:820–30.CrossRefPubMed Junge N, Junge C, Schröder J, et al. Pediatric cirrhotic cardiomyopathy: impact on liver transplant outcomes. Liver Transpl. 2018;24:820–30.CrossRefPubMed
30.
go back to reference Ward LM, Weber DR, Munns CF, Högler W, Zemel BS. A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents. J Clin Endocrinol Metab. 2020;105:e2088–97.CrossRefPubMed Ward LM, Weber DR, Munns CF, Högler W, Zemel BS. A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents. J Clin Endocrinol Metab. 2020;105:e2088–97.CrossRefPubMed
31.
go back to reference Loomes KM, Spino C, Goodrich NP, et al. Bone density in children with chronic liver disease correlates with growth and cholestasis. Hepatology. 2019;69:245–57.CrossRefPubMed Loomes KM, Spino C, Goodrich NP, et al. Bone density in children with chronic liver disease correlates with growth and cholestasis. Hepatology. 2019;69:245–57.CrossRefPubMed
33.
go back to reference Ciancia S, Högler W, Sakkers RJB, et al. Osteoporosis in children and adolescents: how to treat and monitor? Eur J Pediatr. 2023;182:501–11.CrossRefPubMed Ciancia S, Högler W, Sakkers RJB, et al. Osteoporosis in children and adolescents: how to treat and monitor? Eur J Pediatr. 2023;182:501–11.CrossRefPubMed
34.
go back to reference Högler W, Baumann U, Kelly D. Growth and bone health in chronic liver disease and following liver transplantation in children. Pediatr Endocrinol Rev. 2010;7:266–74.PubMed Högler W, Baumann U, Kelly D. Growth and bone health in chronic liver disease and following liver transplantation in children. Pediatr Endocrinol Rev. 2010;7:266–74.PubMed
Metadata
Title
Systemic Complications Secondary to Chronic Liver Disease
Authors
Rory Mannion
Emer Fitzpatrick
Publication date
13-07-2023
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 3/2024
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-023-04694-7

Other articles of this Issue 3/2024

Indian Journal of Pediatrics 3/2024 Go to the issue